跳至主要内容
临床试验/NCT05556876
NCT05556876已完成不适用

Effect of Oral Nutritional Supplements on Muscle Strength in Older Patients at Nutritional Risk Discharged With a Rehabilitation Plan

Herlev and Gentofte Hospital2 个研究点 分布在 1 个国家目标入组 123 人开始时间: 2023年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
123
试验地点
2
主要终点
Leg Muscle strength

研究概览

简要总结

The purpose of the study is to investigate whether an extra intake of energy and protein in the form of nutritional drinks twice a day for 12 weeks can improve muscle strength, muscle mass, quality of life and the implementation of rehabilitation in elderly patients at nutritional risk who are discharged to municipal rehabilitation

详细描述

The study is a single-blind randomised study where the subjects will be randomly divided into two groups. A group that must consume nutritional drinks in connection with their rehabilitation and a group that must do nothing extra. Based on a statistical power calculation, we will include a total of 124 patients.

In connection with the experiment, different data will be collected three times, in connection with the discharge from the hospital, after 6 weeks via the telephone and after 12 weeks. During a home visit. Here, various questionnaires will have to be answered and data on muscle strength and muscle mass will be collected. Further CRP, vitamin D status and EPA/DHA content in blood will be assessed.

In addition, data is collected from the patient's medical record about e.g. readmissions

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

two set of files

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women aged ≥ 65 years old
  • Independent stand function
  • Able to speak and understand Danish
  • At nutritional risk according to NRS-2002
  • (Expected to be) discharged with a new rehabilitation plan
  • Admitted to the medical and orthopaedic departments of Gentofte or Herlev Hospital

排除标准

  • Active cancer
  • Renal insufficiency (eGFR < 27 mL/min/1.73m2)
  • Cognitive impairment (not able to comprehend the purpose of the study/give informed consent)
  • Terminal disease
  • Exclusively receiving texture modified food, enteral or parenteral nutrition
  • Planning to lose weight/go on a special diet
  • Planned transfer to other hospitals/departments
  • Pacemaker/other implanted electrical stimulants (due to Bio-Impedance Analysis (BIA)
  • Taking fish-oil supplements as a medical prescription due to hypertriglyceridemia
  • Taking fish-oil supplements for other reasons and do not wish to stop this during the study period

研究组 & 干预措施

Intervention

Active Comparator

the intervention group will be provided with oral nutritional supplements for 12 weeks after discharge

干预措施: Protein omega-3 (Dietary Supplement)

Control

No Intervention

the control group will receive usual care after discharge

结局指标

主要结局

Leg Muscle strength

时间窗: change from baseline to 12 weeks follow-up

Chair stand

次要结局

  • Hand grip Muscle strength(change from baseline to 12 weeks follow-up)
  • Health related quality of life(Change from baseline to 6 and 12 weeks follow-up)
  • Activities of daily living(Change from baseline to 6 and 12 weeks follow-up)
  • energy and protein intake(at 12 weeks follow-up)
  • Appetite(Change from baseline to 12 week follow-up)
  • Muscle mass(Change from baseline to 12 week follow-up)
  • Frailty(Change from baseline to 12 weeks follow-up)
  • initiation and completion of rehabilitation(at 12 week follow-up)
  • readmissions(30 days and 38 weeks after discharge)
  • compliance to oral nutritional supplements(at 12 weeks follow-up)
  • mortality(30 days and 38 weeks after discharge)
  • inflammation(change from baseline to 12 weeks follow-up)
  • vitamin D status(change from baseline to 12 weeks follow-up)
  • Hydration status(Change from Baseline to 12 weeks follow up)
  • Hand grip Muscle strength(change from baseline to 12 weeks follow-up)
  • energy and protein intake(at 12 weeks follow-up)
  • Appetite(Change from baseline to 12 week follow-up)
  • Muscle mass(Change from baseline to 12 week follow-up)
  • Frailty(Change from baseline to 12 weeks follow-up)
  • initiation and completion of rehabilitation(at 12 week follow-up)
  • compliance to oral nutritional supplements(at 12 weeks follow-up)
  • inflammation(change from baseline to 12 weeks follow-up)
  • vitamin D status(change from baseline to 12 weeks follow-up)
  • Hydration status(Change from Baseline to 12 weeks follow up)
  • Health related quality of life(Change from baseline to 6 and 12 weeks follow-up)
  • Activities of daily living(Change from baseline to 6 and 12 weeks follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anne Marie Beck

Senior researcher

Herlev and Gentofte Hospital

研究点 (2)

Loading locations...

相似试验